Microarray analysis of mdx mice expressing high levels of utrophin: therapeutic implications for dystrophin deficiency.
Duchenne Muscular Dystrophy (DMD) is a fatal muscle wasting disorder caused by dystrophin deficiency. Previous work suggested that increased expression of the dystrophin-related protein utrophin in the mdx mouse can reduce the dystrophic pathophysiology. Physiological tests showed that the transgeni...
Main Authors: | Baban, D, Davies, K |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2008
|
Registos relacionados
-
Functional rescue of dystrophin-deficient mdx mice by a chimeric peptide-PMO
Por: Yin, H, et al.
Publicado em: (2010) -
Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice.
Por: Rafael, J, et al.
Publicado em: (2000) -
Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system.
Por: Squire, S, et al.
Publicado em: (2002) -
A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.
Por: Yin, H, et al.
Publicado em: (2009) -
Rescu of severely affected dystrophin/utrophin deficient mice by morpholino-oligomer mediated exon skipping
Por: Goyenvalle, A, et al.
Publicado em: (2010)